Chandra Bhagat Pharma Ltd. is significantly underperforming its peers across key financial metrics, showing no revenue growth, earnings, or profitability. The company appears to be financially stressed with a debt-equity ratio of zero, but this is coupled with an absence of returns and growth, making it a concern in the current competitive landscape.

• • Chandra Bhagat Pharma has no revenue or earnings growth, making it a laggard in comparison to peers.
• • The company has a zero debt-equity ratio, indicating no debt but also raises concerns about growth prospects.
• • Compared to peers, Chandra Bhagat Pharma's valuation metrics are unattractive, with high PE ratios and no profitability.